A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders.
暂无分享,去创建一个
C. McDougle | G. Pelton | D. Cohen | L. Price | J. Holmes | D. Carlson | Janice P. Holmes | Derek C. Carlson | D. C. Carlson
[1] L. J. Barnhill,et al. Risperidone and Explosive Aggressive Autism , 1997, Journal of autism and developmental disorders.
[2] J. Overall,et al. Neuroleptic-related dyskinesias in autistic children: a prospective, longitudinal study. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.
[3] E. Frischauf. Drug therapy in autism. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.
[4] C. McDougle,et al. Risperidone treatment of children and adolescents with pervasive developmental disorders: a prospective open-label study. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.
[5] M. Rubin. Use of Atypical Antipsychotics in Children with Mental Retardation, Autism, and Other Developmental Disabilities , 1997 .
[6] A. Hardan,et al. Case study: risperidone treatment of children and adolescents with developmental disorders. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.
[7] W. Klykylo,et al. Risperidone and tardive dyskinesia. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.
[8] C. McDougle,et al. Effects of tryptophan depletion in drug-free adults with autistic disorder. , 1996, Archives of general psychiatry.
[9] C. McDougle,et al. A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. , 1996, Archives of general psychiatry.
[10] B. Leventhal,et al. The serotonin system in autism. , 1996, Current opinion in pediatrics.
[11] T. Byrne,et al. Case study: anorexia nervosa and autistic disorder in an adolescent girl. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.
[12] C. McDougle,et al. A case-controlled study of repetitive thoughts and behavior in adults with autistic disorder and obsessive-compulsive disorder. , 1995, The American journal of psychiatry.
[13] A. Labelle,et al. Risperidone in the Treatment of Pervasive Developmental Disorder , 1994, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[14] S. Marder,et al. Risperidone in the treatment of schizophrenia. , 1994, The American journal of psychiatry.
[15] J. Leysen,et al. Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity. , 1994, The Journal of clinical psychiatry.
[16] J. Rapoport,et al. A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. , 1993, Archives of general psychiatry.
[17] C. McDougle,et al. Acute tryptophan depletion in autistic disorder: A controlled case study , 1993, Biological Psychiatry.
[18] A Labelle,et al. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. , 1993, Journal of clinical psychopharmacology.
[19] J. Rapoport,et al. Differential response of seven subjects with autistic disorder to clomipramine and desipramine. , 1992, The American journal of psychiatry.
[20] W. Goodman,et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. , 1989, Archives of general psychiatry.
[21] W. Goodman,et al. The Yale-Brown Obsessive Compulsive Scale. II. Validity. , 1989, Archives of general psychiatry.
[22] A. Couteur,et al. Autism diagnostic interview: A standardized investigator-based instrument , 1989, Journal of autism and developmental disorders.
[23] T. Ordoña. Handbook of Autism and Pervasive Developmental Disorders , 1989 .
[24] R. Perry,et al. Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms. , 1984, The American journal of psychiatry.
[25] C. Gillberg,et al. Childhood psychosis and monoamine metabolites in spinal fluid , 1983, Journal of autism and developmental disorders.
[26] C. Pataki,et al. Risperidone in children and adolescents with pervasive developmental disorder: pilot trial and follow-up. , 1997, Journal of child and adolescent psychopharmacology.
[27] H. Demb. Risperidone in young children with pervasive developmental disorders and other developmental disabilities. , 1996, Journal of child and adolescent psychopharmacology.
[28] S. Fisman,et al. Use of risperidone in pervasive developmental disorders: a case series. , 1996, Journal of child and adolescent psychopharmacology.
[29] S. Cohen,et al. Clinical and economic aspects of risperidone treatment in adults with mental retardation and behavioral disturbance. , 1996, Psychopharmacology bulletin.
[30] N. Carrey,et al. Risperidone Effects in Treatment-Resistant Adolescents: Preliminary Case Reports , 1995 .
[31] C. McDougle,et al. Risperidone in Adults with Autism or Pervasive Developmental Disorder , 1995 .
[32] George McCloskey,et al. Leiter International Performance Scale , 1987 .
[33] F. Volkmar,et al. Handbook of Autism and Pervasive Developmental Disorders , 1987 .
[34] B. Freeman,et al. A scale for rating symptoms of patients with the syndrome of autism in real life settings. , 1986, Journal of the American Academy of Child Psychiatry.
[35] D. Wechsler. Manual for the Wechsler Adult Intelligence Scale. , 1955 .